162 related articles for article (PubMed ID: 22472273)
1. Alzheimer's disease 2012: the great amyloid gamble.
Marchesi VT
Am J Pathol; 2012 May; 180(5):1762-7. PubMed ID: 22472273
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?
Saxena U
Expert Opin Ther Targets; 2010 Dec; 14(12):1273-7. PubMed ID: 21058918
[TBL] [Abstract][Full Text] [Related]
3. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
[TBL] [Abstract][Full Text] [Related]
4. Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.
Asih PR; Chatterjee P; Verdile G; Gupta VB; Trengove RD; Martins RN
Neurodegener Dis Manag; 2014; 4(5):363-78. PubMed ID: 25405650
[TBL] [Abstract][Full Text] [Related]
5. Modulating metals as a therapeutic strategy for Alzheimer's disease.
Hung LW; Barnham KJ
Future Med Chem; 2012 May; 4(8):955-69. PubMed ID: 22650238
[TBL] [Abstract][Full Text] [Related]
6. The molecular pathology of Alzheimer's disease.
Harrington CR
Neuroimaging Clin N Am; 2012 Feb; 22(1):11-22, vii. PubMed ID: 22284730
[TBL] [Abstract][Full Text] [Related]
7. Disease modifying drugs targeting β-amyloid.
Ozudogru SN; Lippa CF
Am J Alzheimers Dis Other Demen; 2012 Aug; 27(5):296-300. PubMed ID: 22815077
[TBL] [Abstract][Full Text] [Related]
8. Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is 'too big to fail'.
Castellani RJ; Smith MA
J Pathol; 2011 Jun; 224(2):147-52. PubMed ID: 21557219
[TBL] [Abstract][Full Text] [Related]
9. Preclinical success against Alzheimer's disease with an old drug.
LaFerla FM
N Engl J Med; 2012 Aug; 367(6):570-2. PubMed ID: 22873540
[No Abstract] [Full Text] [Related]
10. Enoxaparin treatment administered at both early and late stages of amyloid β deposition improves cognition of APPswe/PS1dE9 mice with differential effects on brain Aβ levels.
Timmer NM; van Dijk L; van der Zee CE; Kiliaan A; de Waal RM; Verbeek MM
Neurobiol Dis; 2010 Oct; 40(1):340-7. PubMed ID: 20600909
[TBL] [Abstract][Full Text] [Related]
11. [Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?].
Buée L; Blum D; Bombois S; Buée-Scherrer V; Caillet-Boudin ML; Colin M; Deramecourt V; Dhaenens CM; Galas MC; Hamdane M; Humez S; Maurage CA; Pasquier F; Sablonnière B; Schraen-Maschke S; Sergeant N
Therapie; 2010; 65(5):401-7. PubMed ID: 21144474
[TBL] [Abstract][Full Text] [Related]
12. The amyloid cascade hypothesis has misled the pharmaceutical industry.
Biochem Soc Trans; 2011 Aug; 39(4):920-3. PubMed ID: 21787324
[TBL] [Abstract][Full Text] [Related]
13. Current therapeutic strategy in Alzheimer's disease.
Singh S; Kushwah AS; Singh R; Farswan M; Kaur R
Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1651-64. PubMed ID: 23161037
[TBL] [Abstract][Full Text] [Related]
14. Effects of sex hormones on Alzheimer's disease-associated β-amyloid oligomer formation in vitro.
Morinaga A; Ono K; Takasaki J; Ikeda T; Hirohata M; Yamada M
Exp Neurol; 2011 Apr; 228(2):298-302. PubMed ID: 21281631
[TBL] [Abstract][Full Text] [Related]
15. Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease.
Timmer NM; Herbert MK; Kleinovink JW; Kiliaan AJ; De Waal RM; Verbeek MM
Neuropathol Appl Neurobiol; 2010 Oct; 36(6):478-86. PubMed ID: 20831743
[TBL] [Abstract][Full Text] [Related]
16. Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease.
Haas C
J Alzheimers Dis; 2012; 28(2):241-81. PubMed ID: 21987594
[TBL] [Abstract][Full Text] [Related]
17. Amyloid clearance as a treatment target against Alzheimer's disease.
Kurz A; Perneczky R
J Alzheimers Dis; 2011; 24 Suppl 2():61-73. PubMed ID: 21422524
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease: β-amyloid plaque formation in human brain.
Seeman P; Seeman N
Synapse; 2011 Dec; 65(12):1289-97. PubMed ID: 21633975
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease: from pathology to therapeutic approaches.
Jakob-Roetne R; Jacobsen H
Angew Chem Int Ed Engl; 2009; 48(17):3030-59. PubMed ID: 19330877
[TBL] [Abstract][Full Text] [Related]
20. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.
Joachim CL; Mori H; Selkoe DJ
Nature; 1989 Sep; 341(6239):226-30. PubMed ID: 2528696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
